×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Savara (NASDAQ:SVRA) Price Target Raised to $11.00 at Oppenheimer
Defense World
Savara (NASDAQ:SVRA – Free Report) had its target price hoisted by Oppenheimer from $9.50 to $11.00 in a report issued on Tuesday morning,...
11 hours ago
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society ...
Business Wire
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a...
3 days ago
Savara shares target raised by Oppenheimer on positive aPAP outlook
Investing.com
On Tuesday, Oppenheimer has raised the price target for Savara Inc. (NASDAQ:SVRA) shares to $11.00, marking an increase from the previous...
1 day ago
Savara launches aPAP ClearPath blood test for rare lung disease
Medical Device Network
Savara has announced the launch of aPAP ClearPath, a new blood test designed to aid US physicians in diagnosing autoimmune pulmonary.
5 months ago
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
Yahoo Finance
LANGHORNE, Pa., March 06, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases,...
2 months ago
Savara (NASDAQ:SVRA) Trading Down 4%
MarketBeat
Savara (NASDAQ:SVRA) Stock Price Down 4%
1 day ago
SVRA Stock Quote Price and Forecast
CNN
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of...
2 months ago
Savara Insiders Sold US$632k Of Shares Suggesting Hesitancy
Simply Wall Street
Savara Insiders Sold US$632k Of Shares Suggesting Hesitancy ... Savara Inc. (NASDAQ:SVRA) shareholders may have reason to be concerned, as several...
1 month ago
Savara Announces New Employment Inducement Grant
Business Wire
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of...
5 days ago
Savara Reports First Quarter 2024 Financial Results and Provides Business Update
Business Wire
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases,...
2 weeks ago